Search Results for 'Cancer-Her2'

Cancer-Her2 published presentations and documents on DocSlides.

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

by marina-yarberry

Management of HER2 Over-Expressed Breast Cancer i...

Her2 + Breast Cancer Laura

Her2 + Breast Cancer Laura

by ximena

Bidstrup. Mrs B is a 49 . yo. woman who attended ...

Module 9: HER2-Positive and

Module 9: HER2-Positive and

by norah

Triple-Negative Breast Cancer. Jamie Carroll, APRN...

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

by danika-pritchard

ASCO-CAP Recommendations For HER2 Testing in Brea...

Metastatic HER2-Positive Breast Cancer: Treatment Selection

Metastatic HER2-Positive Breast Cancer: Treatment Selection

by test

First . Line and Beyond. Moderator:. Joseph Gligo...

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

by carny

Heather M. Gage, MD, Avanti . Rangnekar. , Robert ...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

by danika-pritchard

Clinical Practice Guideline Update. American Soci...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

by danika-pritchard

Clinical Practice Guideline Update. American Soci...

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

by arya

Luminal B-like (HER2-positive):!ER-positive!HER2-p...

Changes in Breast Cancer Reports After Second Opinion

Changes in Breast Cancer Reports After Second Opinion

by unita

Dr. Vicente Marco. Department of Pathology. Hospit...

Updates in the Treatment of Breast cancer

Updates in the Treatment of Breast cancer

by alexa-scheidler

Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...

Metastatic Breast Cancer: A Medical Update

Metastatic Breast Cancer: A Medical Update

by liane-varnes

Jennifer M. Matro, MD. Rena Rowan Breast Center. ...

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

by debby-jeon

Monica Brown, MPH, PhD. . California Cancer Regi...

Metastatic triple-positive

Metastatic triple-positive

by marcos147

breast. . cancer. . needs. . different. . ther...

Module 9: HER2-Positive and Triple-Negative BC

Module 9: HER2-Positive and Triple-Negative BC

by unita

Percent with Patients. Number of Patients (Median)...

CA BREAST D r S ana

CA BREAST D r S ana

by oconnor

ishtiaq. . FCPS R3 general surgery unit one UKSO...

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

by gelbero

Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...

Antibody–Drug Conjugates in Development for Non-

Antibody–Drug Conjugates in Development for Non-

by elizabeth

s. mall Cell . Lung Cancer. , Gastric Cancer, and ...

Central Asian Journal of

Central Asian Journal of

by cady

15 Medical and Pharmaceutical Sciences Innovation ...

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

by Kingslayer

A. University of Tennessee Medical Center – Knox...

Endocrine resistance: molecular pathways and rational development of targeted therapies

Endocrine resistance: molecular pathways and rational development of targeted therapies

by spottletoefacebook

Grazia Arpino. Università di Napoli Federico II. ...

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

by delcy

Trastuzumab-emtansine. : A . very. . nice. . poi...

2020 Year in Review: Breast Cancer

2020 Year in Review: Breast Cancer

by caroline

Lisa A. Carey MD, . ScM. University of North Carol...

Denise A. Yardley, MD Sarah Cannon Research Institute

Denise A. Yardley, MD Sarah Cannon Research Institute

by lily

Senior Investigator, . Breast Cancer Research. Ten...

Antibody–Drug Conjugates

Antibody–Drug Conjugates

by wang

in Development for . Breast Cancer. Sara A. Hurvit...

Nanotek & Expo 2014

Nanotek & Expo 2014

by DaintyLittlePrincess

Biodegradable . nanobrushes. for drug delivery. ...

Product Pipeline Neratinib

Product Pipeline Neratinib

by coursion

across the breast cancer therapy spectrum. Phase I...

ID DB06366 CATEGORY

ID DB06366 CATEGORY

by luanne-stotts

Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...

by tawny-fly

Gradishar. . MD, FACP. Betsy . Bramsen. Profess...

What’s new in Anatomic Pathology Quality Assurance?

What’s new in Anatomic Pathology Quality Assurance?

by alida-meadow

. Raouf E. Nakhleh, MD. Mayo Clinic Florida. Dis...

ORIGINALARTICLEBREASTONCOLOGY

ORIGINALARTICLEBREASTONCOLOGY

by emery

SentinelLymphNodeBiopsyAfterNeoadjuvantChemotherap...

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

by katrgolden

Contents PageIntended Use 4Summary and Explanation...

Systemic Therapy of Breast Cancer

Systemic Therapy of Breast Cancer

by abigail

Jo Anne Zujewski, M.D.. June 2019. Thimphu. , Bhut...

Cutoff value for prominent biomarkers of breast cancer on overall survival using CART analysis

Cutoff value for prominent biomarkers of breast cancer on overall survival using CART analysis

by eddey

Pragya Kumari. 1. , . Atanu. Bhattacharjee. 2. , ...

Adjuvant Therapy For Breast Cancer

Adjuvant Therapy For Breast Cancer

by eddey

. Breast Cancer | . Epidemiology- Australia. Austr...

Immunotherapy of Breast Cancer

Immunotherapy of Breast Cancer

by WhereTheWildThingsAre

World Congress on Breast Cancer . ...

Breast Cancer in Older Patients

Breast Cancer in Older Patients

by ButterflyKisses

Key Issues. Etienne GC . Brain. , MD . PhD. Instit...

Chemotherapeutic Treatment Options for Triple Negative Breast Cancer

Chemotherapeutic Treatment Options for Triple Negative Breast Cancer

by iris

Lauren Barney. April 17, 2013. Breast Cancer Subty...

Brea st cancer G eneral

Brea st cancer G eneral

by slayrboot

. in. f. orma. t. ion. Risk. . f. a. ct. ors. Pro...

Breast Cancer Highlights From San Antonio

Breast Cancer Highlights From San Antonio

by tatyana-admore

Joyce O'Shaughnessy, MD. Kimberly Blackwell, MD. ...